Review

na v 1 2 (NeuroMab)

NeuroMab is a verified supplier

NeuroMab manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

NeuroMab na v 1 2

Na V 1.2 labels Domain 3 in majority of afferents, first nodes, and stromal paranodes. (A, A’) Na V 1.2 ( green ) labels the calyx outer surfaces (Domain 3, arrows ) of D afferents in the extrastriolar zone of the utricular macula from an adult female rat. The calyx inner surfaces are marked with Caspr1 ( Caspr, red in A). The beginning of two parent axons (arrowheads) can be seen in the neuroepithelium, but could not be traced into the stroma, where the heminodes of most D units are located, presumably because they go out of the plane of this single section. Inset in A’, upper right , schematic of entire calyx, showing Domain 3 in red. (B) Na V 1.2 antibody ( green ) labels mostly stromal nodes ( arrowheads ), but not heminodes ( arrows ), both of which are marked with an ezrin antibody ( red ). (C) Deeper in the stroma of the crista in a maximum intensity projection, many nodes can be observed. The Na V 1.2 ( green ) extends beyond the boundaries of the node, marked by ezrin ( red ). C insets . Na V 1.6 antibody (in this case red ) immunostains two nodes of Ranvier in the stroma of a rat saccular macula. Similar to (C), Na V 1.2 ( green ) also stains the nodes (seen after removal of the Na V 1.6 immunolabel ( red ) in the bottom half of each inset) and extends well beyond each node into the paranode. Scale bars: A–C = 10 µm; C inset = 5 µm.

Na V 1 2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 94/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/na+v+1+2/Anti-Nav1%2E2+Na%2B+Channel+Antibody/pmc12852067-2-0-5
Average 94 stars, based on 43 article reviews

na v 1 2 - by Bioz Stars, 2026-09

94/100 stars

Images

1) Product Images from "Distribution of Voltage‐Gated Sodium Channels and Scaffolding Proteins on Vestibular Calyx Ending Delineates the Axon Initial Segment"

Article Title: Distribution of Voltage‐Gated Sodium Channels and Scaffolding Proteins on Vestibular Calyx Ending Delineates the Axon Initial Segment

Journal: The Journal of Comparative Neurology

doi: 10.1002/cne.70127

Figure Legend Snippet: Na V 1.2 labels Domain 3 in majority of afferents, first nodes, and stromal paranodes. (A, A’) Na V 1.2 ( green ) labels the calyx outer surfaces (Domain 3, arrows ) of D afferents in the extrastriolar zone of the utricular macula from an adult female rat. The calyx inner surfaces are marked with Caspr1 ( Caspr, red in A). The beginning of two parent axons (arrowheads) can be seen in the neuroepithelium, but could not be traced into the stroma, where the heminodes of most D units are located, presumably because they go out of the plane of this single section. Inset in A’, upper right , schematic of entire calyx, showing Domain 3 in red. (B) Na V 1.2 antibody ( green ) labels mostly stromal nodes ( arrowheads ), but not heminodes ( arrows ), both of which are marked with an ezrin antibody ( red ). (C) Deeper in the stroma of the crista in a maximum intensity projection, many nodes can be observed. The Na V 1.2 ( green ) extends beyond the boundaries of the node, marked by ezrin ( red ). C insets . Na V 1.6 antibody (in this case red ) immunostains two nodes of Ranvier in the stroma of a rat saccular macula. Similar to (C), Na V 1.2 ( green ) also stains the nodes (seen after removal of the Na V 1.6 immunolabel ( red ) in the bottom half of each inset) and extends well beyond each node into the paranode. Scale bars: A–C = 10 µm; C inset = 5 µm.

Techniques Used: Immunolabeling

Immunolabeling:

Article Title: Distribution of Voltage‐Gated Sodium Channels and Scaffolding Proteins on Vestibular Calyx Ending Delineates the Axon Initial Segment
Article Snippet: Na V 1.2 (ms) , NeuroMab , 75‐024 RRID:AB_2184030 , , X (Br) , , X , , Datasheet.

Article Title: Sodium channel endocytosis drives axon initial segment plasticity
Article Snippet: The following antibodies were used in this study: Na V 1.2 (NeuroMab/Antibodies Incorporated #75-024), Na V 1.6 (Alomone Labs #ASC-009 and NeuroMab/Antibodies Incorporated #73-026), Pan-Nav (Sigma, #S8809), AnkG (Life technologies #33-8800, Neuromab/Antibodies Incorporated #75-146 and Synaptic systems #386-005), βIV-spectrin (Biotrend, provided by Maren Engelhardt, Johnnes-Kepler-University, Linz, Austria), MAP2 (Abcam/Bio Connect #ab5392), GFP (MBL International/Sanbio #598 and Abcam #ab13970).Corresponding secondary antibodies Alexa-conjugated 405, 488, 568, 594 or 647 goat anti-mouse, anti-mouse IgG1/IgG2a, anti-rabbit, anti guinea-pig or anti-chicken were used (Life Technologies), as well as streptavidin Alexa-633 conjugate (Life Technologies) for the detection of biocytin filled neurons.

Image Search Results

Journal: The Journal of Comparative Neurology

Article Title: Distribution of Voltage‐Gated Sodium Channels and Scaffolding Proteins on Vestibular Calyx Ending Delineates the Axon Initial Segment

doi: 10.1002/cne.70127

Figure Lengend Snippet: Na V 1.2 labels Domain 3 in majority of afferents, first nodes, and stromal paranodes. (A, A’) Na V 1.2 ( green ) labels the calyx outer surfaces (Domain 3, arrows ) of D afferents in the extrastriolar zone of the utricular macula from an adult female rat. The calyx inner surfaces are marked with Caspr1 ( Caspr, red in A). The beginning of two parent axons (arrowheads) can be seen in the neuroepithelium, but could not be traced into the stroma, where the heminodes of most D units are located, presumably because they go out of the plane of this single section. Inset in A’, upper right , schematic of entire calyx, showing Domain 3 in red. (B) Na V 1.2 antibody ( green ) labels mostly stromal nodes ( arrowheads ), but not heminodes ( arrows ), both of which are marked with an ezrin antibody ( red ). (C) Deeper in the stroma of the crista in a maximum intensity projection, many nodes can be observed. The Na V 1.2 ( green ) extends beyond the boundaries of the node, marked by ezrin ( red ). C insets . Na V 1.6 antibody (in this case red ) immunostains two nodes of Ranvier in the stroma of a rat saccular macula. Similar to (C), Na V 1.2 ( green ) also stains the nodes (seen after removal of the Na V 1.6 immunolabel ( red ) in the bottom half of each inset) and extends well beyond each node into the paranode. Scale bars: A–C = 10 µm; C inset = 5 µm.

Article Snippet: Na V 1.2 (ms) , NeuroMab , 75‐024 RRID:AB_2184030 , , X (Br) , , X , , Datasheet.

Techniques: Immunolabeling

PTPRN interacts with Na V 1.2 channels and negatively modulates Na V 1.2‐mediated current. A) Workflow showing experimental procedures for identification of PTPRN interactors and whole‐cell patch‐clamp recordings. B) Top panel: Classification of the interactors identified in IP‐MS experiments with GO enrichment analysis. Bottom panel: Classification of the interactors identified in IP‐MS experiments with KEGG enrichment analysis. C) Tandem mass spectrometric spectra of a unique peptide of Na V 1.2 identified in the IP‐PTPRN sample. D) Staining for Na V 1.2 (top) and PTPRN (bottom) in hippocampal DG region of adult mice. Scale bar, 50 µm. E) Immunoblot analysis of Na V 1.2 and PTPRN in IP‐PTPRN (left) and IP‐Na V 1.2 (right) samples prepared from mouse hippocampal lysate. F) Immunoblot analysis of HA‐Na V 1.2 and PTPRN‐Flag in IP‐Flag (Left) and IP‐HA (Right) samples prepared from HEK‐293T cell lysate. G) Representative whole‐cell currents recorded from HEK‐293T cells expressing Na V 1.2 and empty vector ( n = 18), Na V 1.2 and PTPRN in a 1:1 ratio ( n = 18), or Na V 1.2 and PTPRN in a 1:2 ratio ( n = 20). Currents were evoked by 5 mV steps depolarization from −90 to 45 mV and cells were held at ‐90 mV. H) Current density versus voltage relationship for the cells described in (G). Currents in all figures were normalized to cell capacitance. I) Graph depicting the voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. J) Current density versus voltage relationship for the primary cortical neurons isolated from PTPRN‐KO ( n = 13) or PTPRN‐WT mice ( n = 16). Currents in all figures were normalized to cell capacitance. K) Validation of Scn8a deletion by western blot analysis using primary cortical neurons. L) Validation of PTPRN knockdown efficiency by western blot analysis using primary cortical neurons infected with lentivirus containing shRNA‐PTPRN or nonsilencing lentivirus for 7 days. M) RT‐PCR analysis of PTPRN in primary cortical neurons described in (L). The levels of mRNA were normalized to those of β‐Actin. n = 3, **** p < 0.0001, #### p < 0.0001, $$$$ p < 0.0001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. N) Current density versus voltage relationship for the primary cortical neurons isolated from Scn8a‐KO mice infected with lentivirus containing shRNA‐PTPRN#3 ( n = 15) or nonsilencing lentivirus ( n = 15) for 7 days. Currents in all figures were normalized to cell capacitance. Data are represented as mean ± s.e.m.

Journal: Advanced Science

Article Title: A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na V 1.2 Sodium Channels

doi: 10.1002/advs.202400560

Figure Lengend Snippet: PTPRN interacts with Na V 1.2 channels and negatively modulates Na V 1.2‐mediated current. A) Workflow showing experimental procedures for identification of PTPRN interactors and whole‐cell patch‐clamp recordings. B) Top panel: Classification of the interactors identified in IP‐MS experiments with GO enrichment analysis. Bottom panel: Classification of the interactors identified in IP‐MS experiments with KEGG enrichment analysis. C) Tandem mass spectrometric spectra of a unique peptide of Na V 1.2 identified in the IP‐PTPRN sample. D) Staining for Na V 1.2 (top) and PTPRN (bottom) in hippocampal DG region of adult mice. Scale bar, 50 µm. E) Immunoblot analysis of Na V 1.2 and PTPRN in IP‐PTPRN (left) and IP‐Na V 1.2 (right) samples prepared from mouse hippocampal lysate. F) Immunoblot analysis of HA‐Na V 1.2 and PTPRN‐Flag in IP‐Flag (Left) and IP‐HA (Right) samples prepared from HEK‐293T cell lysate. G) Representative whole‐cell currents recorded from HEK‐293T cells expressing Na V 1.2 and empty vector ( n = 18), Na V 1.2 and PTPRN in a 1:1 ratio ( n = 18), or Na V 1.2 and PTPRN in a 1:2 ratio ( n = 20). Currents were evoked by 5 mV steps depolarization from −90 to 45 mV and cells were held at ‐90 mV. H) Current density versus voltage relationship for the cells described in (G). Currents in all figures were normalized to cell capacitance. I) Graph depicting the voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. J) Current density versus voltage relationship for the primary cortical neurons isolated from PTPRN‐KO ( n = 13) or PTPRN‐WT mice ( n = 16). Currents in all figures were normalized to cell capacitance. K) Validation of Scn8a deletion by western blot analysis using primary cortical neurons. L) Validation of PTPRN knockdown efficiency by western blot analysis using primary cortical neurons infected with lentivirus containing shRNA‐PTPRN or nonsilencing lentivirus for 7 days. M) RT‐PCR analysis of PTPRN in primary cortical neurons described in (L). The levels of mRNA were normalized to those of β‐Actin. n = 3, **** p < 0.0001, #### p < 0.0001, $$$$ p < 0.0001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. N) Current density versus voltage relationship for the primary cortical neurons isolated from Scn8a‐KO mice infected with lentivirus containing shRNA‐PTPRN#3 ( n = 15) or nonsilencing lentivirus ( n = 15) for 7 days. Currents in all figures were normalized to cell capacitance. Data are represented as mean ± s.e.m.

Article Snippet: To investigate the mechanism of the regulation on Na V 1.2 by PTPRN, 80 μ m Dynasore (Abcam), [ ] 1 μ m TAK‐243 (TargetMol), [ ] 20 μ m Pitstop2 (GLPBIO), [ ] or 50 μ m Heclin (GLPBIO) [ ] were added into the medium 2 h before the electrophysiology recording.

Techniques: Patch Clamp, Protein-Protein interactions, Staining, Western Blot, Expressing, Plasmid Preparation, Activation Assay, Isolation, Biomarker Discovery, Knockdown, Infection, shRNA, Reverse Transcription Polymerase Chain Reaction

$PTPRN promotes Na V 1.2 channel internalization through ubiquitin‐dependent endocytosis. A) Schematic of the effect of inhibitors on the trafficking and ubiquitination of proteins. B) Left panel: Immunoblot analysis of cell surface biotinylation performed in primary cortical neurons infected with lentivirus containing shRNA‐PTPRN#3 or nonsilencing lentivirus for 7 days. Total lysates (total) and biotinylated fractions (membrane) were analyzed by western blot analysis. Right panel: Quantification of Na V 1.2 total expression and surface expression. n = 3, * p < 0.05, two‐way ANOVA with Bonferroni's multiple‐comparisons test. C) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment using dynasore (80 µ m , 2 h). n = 21 for all samples except Na V 1.2 + PTPRN plus dynasore ( n = 24). D) Graph depicting voltage‐dependence of activation for Na V 1.2 channels described in (C). The lines are the best‐fitted Boltzmann curves. E) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment using TAK‐243 (1 µ m , 2 h). n = 18 and 26 for untreated Na V 1.2 and Na V 1.2 + PTPRN, respectively, and n = 20 and 26 for Na V 1.2 and Na V 1.2 + PTPRN plus TAK‐243, respectively. F) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (E). The lines are the best‐fitted Boltzmann curves. G) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment with Heclin (20 µ m , 2 h). n = 18 and 26 for Na V 1.2 and Na V 1.2 + PTPRN plus Heclin, respectively, and n = 19 for both samples without treatment. H) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. I) Workflow showing experimental procedures for purification of PTPRN intracellular fragment (aa 601–979, PTPRN‐cyto) and TagRFP and whole cell patch‐clamp recordings. J) Left panel: Coomassie blue staining of PTPRN‐cyto (left) or TagRFP (right) after purification and separation by SDS‐PAGE. Right panel: Representative images showing peptide delivery through a pipette. Scale bar, 50 µm. K) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 after intracellular equilibration with 1 µ m PTPRN‐cyto ( n = 25) or TagRFP ( n = 23). L) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (K). The lines are the best‐fitted Boltzmann curves. Data are represented as mean ± s.e.m.$

Journal: Advanced Science

Article Title: A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na V 1.2 Sodium Channels

doi: 10.1002/advs.202400560

Figure Lengend Snippet: PTPRN promotes Na V 1.2 channel internalization through ubiquitin‐dependent endocytosis. A) Schematic of the effect of inhibitors on the trafficking and ubiquitination of proteins. B) Left panel: Immunoblot analysis of cell surface biotinylation performed in primary cortical neurons infected with lentivirus containing shRNA‐PTPRN#3 or nonsilencing lentivirus for 7 days. Total lysates (total) and biotinylated fractions (membrane) were analyzed by western blot analysis. Right panel: Quantification of Na V 1.2 total expression and surface expression. n = 3, * p < 0.05, two‐way ANOVA with Bonferroni's multiple‐comparisons test. C) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment using dynasore (80 µ m , 2 h). n = 21 for all samples except Na V 1.2 + PTPRN plus dynasore ( n = 24). D) Graph depicting voltage‐dependence of activation for Na V 1.2 channels described in (C). The lines are the best‐fitted Boltzmann curves. E) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment using TAK‐243 (1 µ m , 2 h). n = 18 and 26 for untreated Na V 1.2 and Na V 1.2 + PTPRN, respectively, and n = 20 and 26 for Na V 1.2 and Na V 1.2 + PTPRN plus TAK‐243, respectively. F) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (E). The lines are the best‐fitted Boltzmann curves. G) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 and PTPRN in a 1:2 ratio (Na V 1.2 + PTPRN) or Na V 1.2 and empty vector (Na V 1.2), with or without treatment with Heclin (20 µ m , 2 h). n = 18 and 26 for Na V 1.2 and Na V 1.2 + PTPRN plus Heclin, respectively, and n = 19 for both samples without treatment. H) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. I) Workflow showing experimental procedures for purification of PTPRN intracellular fragment (aa 601–979, PTPRN‐cyto) and TagRFP and whole cell patch‐clamp recordings. J) Left panel: Coomassie blue staining of PTPRN‐cyto (left) or TagRFP (right) after purification and separation by SDS‐PAGE. Right panel: Representative images showing peptide delivery through a pipette. Scale bar, 50 µm. K) Current density versus voltage relationship for HEK‐293T cells expressing Na V 1.2 after intracellular equilibration with 1 µ m PTPRN‐cyto ( n = 25) or TagRFP ( n = 23). L) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (K). The lines are the best‐fitted Boltzmann curves. Data are represented as mean ± s.e.m.

Techniques: Ubiquitin Proteomics, Western Blot, Infection, shRNA, Membrane, Expressing, Plasmid Preparation, Activation Assay, Purification, Patch Clamp, Staining, SDS Page, Transferring

PTPRN facilitates ubiquitination of Na V 1.2 channels by recruiting NEDD4L. A) Schematic diagram of Na V 1.2 intracellular regions and Na V 1.2‐1.5 chimeric channels (Na V 1.2/5C and Na V 1.5/2C). B) Immunoblot analysis of HA‐tagged Na V 1.2 intracellular regions and PTPRN‐Flag in IP‐Flag samples prepared from HEK‐293T cell lysate. C) Current density versus voltage relationship for HEK‐293T cells expressing the Na V 1.2/5C chimera and PTPRN in a 1:2 ratio (Na V 1.2/5C + PTPRN) ( n = 26) or the Na V 1.2/5C chimera and empty vector in a 1:2 ratio (Na V 1.2/5C, n = 19). D) Graph depicting voltage dependence of activation for the Na V 1.2/5C chimera described in (C). The lines are the best‐fitted Boltzmann curves. E) Current density versus voltage relationship for HEK‐293T cells expressing the Na V 1.5/2C chimera and PTPRN in a 1:2 ratio (Na V 1.5/2C + PTPRN) or the Na V 1.2/5C chimera and empty vector in a 1:2 ratio (Na V 1.5/2C), n = 20. F) Graph depicting voltage‐dependence of activation for the Na V 1.2/5C chimera described in (E). The lines are the best‐fitted Boltzmann curves. G) Current density versus voltage relationship for HEK‐293T cells expressing wild‐type (WT) Na V 1.2, Na V 1.2 IL‐AA , or Na V 1.2 PPSY‐AAAA mutations with PTPRN or empty vector in a 1:2 ratio. n = 20, 22, 23, 22, and 22 (from up to down in legend). H) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. I) Immunoblot analysis of HA‐tagged NEDD4/NEDD4L and PTPRN‐Flag in IP‐Flag samples prepared from HEK‐293T cell lysate. J) Immunoblot analysis of Na V 1.2, NEDD4L and PTPRN in the IP‐PTPRN sample prepared from human temporal lobe lysate. K) Current density versus voltage relationship for HEK‐293T cells expressing WT Na V 1.2 with or without PTPRN/NEDD4L CS mutation. n = 18, 24, 24, and 23 (from up to down in legend). L) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (K). The lines are the best‐fitted Boltzmann curves. M) Validation of NEDD4L knockdown efficiency by western blot analysis using primary cortical neurons infected with lentivirus containing shRNA‐NEDD4L or nonsilencing lentivirus for 7 days. N) Current density versus voltage relationship for the primary cortical neurons isolated from Scn8a‐KO mice infected with lentivirus containing shRNA‐PTPRN#3 and shRNA‐NEDD4L ( n = 15) or nonsilencing lentivirus ( n = 15) for 7 days. Currents in all figures were normalized to cell capacitance. O) Western blot analysis of indicated proteins in IP‐Na V 1.2 samples prepared from hippocampus of PTPRN‐KO or PTPRN‐WT mice. P) Quantification of Na V 1.2 ubiquitination level (top) and the interaction between Na V 1.2 and NEDD4L (bottom). n = 3, * p < 0.05, *** p < 0.001, unpaired two‐tailed Student's t ‐test. Q) Western blot analysis of indicated proteins in IP‐Na V 1.2 samples prepared from hippocampus of mice infected with control AAV or AAV expressing PTPRN. R) Quantification of Na V 1.2 ubiquitination level (top) and the interaction between Na V 1.2 and NEDD4L (bottom). n = 3, * p < 0.05, ** p < 0.01, unpaired two‐tailed Student's t ‐test. Data are represented as mean ± s.e.m.

Journal: Advanced Science

Article Title: A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na V 1.2 Sodium Channels

doi: 10.1002/advs.202400560

Figure Lengend Snippet: PTPRN facilitates ubiquitination of Na V 1.2 channels by recruiting NEDD4L. A) Schematic diagram of Na V 1.2 intracellular regions and Na V 1.2‐1.5 chimeric channels (Na V 1.2/5C and Na V 1.5/2C). B) Immunoblot analysis of HA‐tagged Na V 1.2 intracellular regions and PTPRN‐Flag in IP‐Flag samples prepared from HEK‐293T cell lysate. C) Current density versus voltage relationship for HEK‐293T cells expressing the Na V 1.2/5C chimera and PTPRN in a 1:2 ratio (Na V 1.2/5C + PTPRN) ( n = 26) or the Na V 1.2/5C chimera and empty vector in a 1:2 ratio (Na V 1.2/5C, n = 19). D) Graph depicting voltage dependence of activation for the Na V 1.2/5C chimera described in (C). The lines are the best‐fitted Boltzmann curves. E) Current density versus voltage relationship for HEK‐293T cells expressing the Na V 1.5/2C chimera and PTPRN in a 1:2 ratio (Na V 1.5/2C + PTPRN) or the Na V 1.2/5C chimera and empty vector in a 1:2 ratio (Na V 1.5/2C), n = 20. F) Graph depicting voltage‐dependence of activation for the Na V 1.2/5C chimera described in (E). The lines are the best‐fitted Boltzmann curves. G) Current density versus voltage relationship for HEK‐293T cells expressing wild‐type (WT) Na V 1.2, Na V 1.2 IL‐AA , or Na V 1.2 PPSY‐AAAA mutations with PTPRN or empty vector in a 1:2 ratio. n = 20, 22, 23, 22, and 22 (from up to down in legend). H) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (G). The lines are the best‐fitted Boltzmann curves. I) Immunoblot analysis of HA‐tagged NEDD4/NEDD4L and PTPRN‐Flag in IP‐Flag samples prepared from HEK‐293T cell lysate. J) Immunoblot analysis of Na V 1.2, NEDD4L and PTPRN in the IP‐PTPRN sample prepared from human temporal lobe lysate. K) Current density versus voltage relationship for HEK‐293T cells expressing WT Na V 1.2 with or without PTPRN/NEDD4L CS mutation. n = 18, 24, 24, and 23 (from up to down in legend). L) Graph depicting voltage dependence of activation for Na V 1.2 channels described in (K). The lines are the best‐fitted Boltzmann curves. M) Validation of NEDD4L knockdown efficiency by western blot analysis using primary cortical neurons infected with lentivirus containing shRNA‐NEDD4L or nonsilencing lentivirus for 7 days. N) Current density versus voltage relationship for the primary cortical neurons isolated from Scn8a‐KO mice infected with lentivirus containing shRNA‐PTPRN#3 and shRNA‐NEDD4L ( n = 15) or nonsilencing lentivirus ( n = 15) for 7 days. Currents in all figures were normalized to cell capacitance. O) Western blot analysis of indicated proteins in IP‐Na V 1.2 samples prepared from hippocampus of PTPRN‐KO or PTPRN‐WT mice. P) Quantification of Na V 1.2 ubiquitination level (top) and the interaction between Na V 1.2 and NEDD4L (bottom). n = 3, * p < 0.05, *** p < 0.001, unpaired two‐tailed Student's t ‐test. Q) Western blot analysis of indicated proteins in IP‐Na V 1.2 samples prepared from hippocampus of mice infected with control AAV or AAV expressing PTPRN. R) Quantification of Na V 1.2 ubiquitination level (top) and the interaction between Na V 1.2 and NEDD4L (bottom). n = 3, * p < 0.05, ** p < 0.01, unpaired two‐tailed Student's t ‐test. Data are represented as mean ± s.e.m.

Techniques: Ubiquitin Proteomics, Western Blot, Expressing, Plasmid Preparation, Activation Assay, Mutagenesis, Biomarker Discovery, Knockdown, Infection, shRNA, Isolation, Two Tailed Test, Control

PTPRN‐Na V 1.2 axis regulates neuronal intrinsic excitability and seizure susceptibility. A) Schematic diagram showing stereotaxic injection of shRNA‐Scn2a AAV in adult PTPRN‐KO mice. B) Infection of AAV expressing shRNA‐Scn2a and EGFP in the hippocampal DG region 14 days after injection. Scale bar, 125 µm. C) Validation of Scn2a knockdown efficiency by RT‐PCR analysis of Scn2a in hippocampal tissues obtained from mice infected with AAV‐containing shRNA‐Scn2a or control AAV for 14 days. The levels of mRNA were normalized to those of β‐Actin. n = 3, ** p < 0.01, unpaired two‐tailed Student's t ‐test. D) Top panel: Validation of Scn2a knockdown efficiency by western blot analysis using hippocampi from mice infected with AAV‐containing shRNA‐Scn2a or control AAV for 14 days. Bottom panel: Quantification of the results by normalizing the protein levels of Na V 1.2 to those of β‐Actin. n = 3, * p < 0.05, unpaired two‐tailed Student's t ‐test. E) Left panel: Representative current‐clamp recordings of DG granule cells from PTPRN‐WT and PTPRN‐KO mice infected with AAV containing shRNA‐Scn2a or control AAV for 14 days. For comparison, the cells were held at ‐80 mV of membrane potential. Right panel: The mean number of APs generated in response to depolarizing current pulses. * p < 0.05, *** p < 0.001, **** p < 0.0001, #### p < 0.0001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. F) Typical APs of DG granule cells from mice described in (E). G) Phase plane plots associated with APs in (F). H) The average AP threshold (left) and peak rising phase dV/dt (right). * p < 0.05, #### p < 0.0001, $$$$ p < 0.0001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. I) Graph depicting the seizure progression in PTPRN‐WT and PTPRN‐KO mice infected with AAV containing shRNA‐Scn2a or control AAV for 14 days, illustrated as mean maximum seizure stage reached by 15, 30, 45, 60, and 75 min after KA administration. n = 6, $ p < 0.05, * p < 0.05, *** p < 0.001, **** p < 0.0001, ### p < 0.001, $$$ p < 0.001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. J) Graph showing time taken to reach each stage of seizure after administration of KA in mice described in (I). n = 6, $$ p < 0.01, **** p < 0.0001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. K) Number of class V seizures within 1 h after KA administration. n = 6, *** p < 0.001, ### p < 0.001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. L) Incidence of maximum seizure stage reached during the course of the experiments in (I). n = 6, **** p < 0.0001, #### p < 0.0001, $$$$ p < 0.0001, Chi‐square test. Data are represented as mean ± s.e.m.

Journal: Advanced Science

Article Title: A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na V 1.2 Sodium Channels

doi: 10.1002/advs.202400560

Figure Lengend Snippet: PTPRN‐Na V 1.2 axis regulates neuronal intrinsic excitability and seizure susceptibility. A) Schematic diagram showing stereotaxic injection of shRNA‐Scn2a AAV in adult PTPRN‐KO mice. B) Infection of AAV expressing shRNA‐Scn2a and EGFP in the hippocampal DG region 14 days after injection. Scale bar, 125 µm. C) Validation of Scn2a knockdown efficiency by RT‐PCR analysis of Scn2a in hippocampal tissues obtained from mice infected with AAV‐containing shRNA‐Scn2a or control AAV for 14 days. The levels of mRNA were normalized to those of β‐Actin. n = 3, ** p < 0.01, unpaired two‐tailed Student's t ‐test. D) Top panel: Validation of Scn2a knockdown efficiency by western blot analysis using hippocampi from mice infected with AAV‐containing shRNA‐Scn2a or control AAV for 14 days. Bottom panel: Quantification of the results by normalizing the protein levels of Na V 1.2 to those of β‐Actin. n = 3, * p < 0.05, unpaired two‐tailed Student's t ‐test. E) Left panel: Representative current‐clamp recordings of DG granule cells from PTPRN‐WT and PTPRN‐KO mice infected with AAV containing shRNA‐Scn2a or control AAV for 14 days. For comparison, the cells were held at ‐80 mV of membrane potential. Right panel: The mean number of APs generated in response to depolarizing current pulses. * p < 0.05, *** p < 0.001, **** p < 0.0001, #### p < 0.0001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. F) Typical APs of DG granule cells from mice described in (E). G) Phase plane plots associated with APs in (F). H) The average AP threshold (left) and peak rising phase dV/dt (right). * p < 0.05, #### p < 0.0001, $$$$ p < 0.0001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. I) Graph depicting the seizure progression in PTPRN‐WT and PTPRN‐KO mice infected with AAV containing shRNA‐Scn2a or control AAV for 14 days, illustrated as mean maximum seizure stage reached by 15, 30, 45, 60, and 75 min after KA administration. n = 6, $ p < 0.05, * p < 0.05, *** p < 0.001, **** p < 0.0001, ### p < 0.001, $$$ p < 0.001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. J) Graph showing time taken to reach each stage of seizure after administration of KA in mice described in (I). n = 6, $$ p < 0.01, **** p < 0.0001, two‐way ANOVA with Bonferroni's multiple‐comparisons test. K) Number of class V seizures within 1 h after KA administration. n = 6, *** p < 0.001, ### p < 0.001, one‐way ANOVA with Bonferroni's multiple‐comparisons test. L) Incidence of maximum seizure stage reached during the course of the experiments in (I). n = 6, **** p < 0.0001, #### p < 0.0001, $$$$ p < 0.0001, Chi‐square test. Data are represented as mean ± s.e.m.

Techniques: Injection, shRNA, Infection, Expressing, Biomarker Discovery, Knockdown, Reverse Transcription Polymerase Chain Reaction, Control, Two Tailed Test, Western Blot, Comparison, Membrane, Generated

Proposed mechanism for PTPRN regulation of Na V 1.2 channels and neuronal intrinsic plasticity. Elevated neuronal activity augments the recruitment of NEDD4L by PTPRN to Na V 1.2 sodium channels. This interaction promotes NEDD4L‐mediated ubiquitination, subsequently leading to the endocytosis of Na V 1.2 channels. The presented regulatory mechanism provides a feedback response to heightened activity within the nervous system, thereby aiding the tuning of neuronal intrinsic plasticity.

Journal: Advanced Science

Article Title: A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na V 1.2 Sodium Channels

doi: 10.1002/advs.202400560

Figure Lengend Snippet: Proposed mechanism for PTPRN regulation of Na V 1.2 channels and neuronal intrinsic plasticity. Elevated neuronal activity augments the recruitment of NEDD4L by PTPRN to Na V 1.2 sodium channels. This interaction promotes NEDD4L‐mediated ubiquitination, subsequently leading to the endocytosis of Na V 1.2 channels. The presented regulatory mechanism provides a feedback response to heightened activity within the nervous system, thereby aiding the tuning of neuronal intrinsic plasticity.

Techniques: Activity Assay, Ubiquitin Proteomics

Review

na v 1 2 (NeuroMab)

Structured Review

Images

1) Product Images from "Distribution of Voltage‐Gated Sodium Channels and Scaffolding Proteins on Vestibular Calyx Ending Delineates the Axon Initial Segment"

Related Articles

Immunolabeling:

Similar Products

Image Search Results